Search - tctmd.com

Displaying 101 - 120 of 319

Sort: Relevancy | Date

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

News Industry News

New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis

September 14, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Todd Neale

August 07, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Yael L. Maxwell

June 03, 2014

News Daily News

Nobori BES Equals Promus Element in Long Lesions

Jason Kahn

May 30, 2014

News Daily News

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Jason Kahn

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Industry News

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

May 13, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

Advertisement

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

COMPARE II: BES, EES Show Similar Outcomes at Three Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Nobori BES Equals Promus Element in Long Lesions

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content